Routine phenobarbital for prevention of neonatal hyperbilirubinemia

Obstetrics and Gynecology

Volumn 47, Issue 3, 1976, Pages 304-308

  Thomas, Charles R ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; PHENOBARBITAL;

DRUG BLOOD LEVEL; DRUG METABOLISM; FETUS; HYPERBILIRUBINEMIA; JAUNDICE; MAJOR CLINICAL STUDY; NEWBORN; ORAL DRUG ADMINISTRATION; PREGNANCY; PREVENTION; PROPHYLAXIS; SERUM;

COSTS AND COST ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; PHENOBARBITAL; PREGNANCY; PRENATAL CARE;

EID: 0017236854     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Poland RL. Odell GR: Physiologic jaundice: The enterohepatic circulation of bilirubin. N Engl J Med 284:1-6. 1971
2. Hatpin TF, Jones AR. Bishop HL, et al: Prophylaxis of neonatal hyperbilirubinemia with phenobarbital. Obstet Gynecol 40:85-90, 1972
3. Mauer AM: Neonatal jaundice-prevention and management. DM 1-31. Feb. 1972
4. Yeung CY, Tam LS, Chan A. et al: Phenobarbitone prophylaxis for neonatal hyperbilirubinemia. Pediatrics 48:372-376. 1971
5. Sinniah D. Tay LK. Dugdale AE: Phenobarbitone in neonatal jaundice. Arch Dis Child 46:712-715. 1971
6. Carswell F, Kerr MN, Dunsmore IR: Sequential trial of effect of phenobarbitone on serum bilirubin of preterm infants. Arch Dis Child 47:621-625. 1972
7. Sisson TRC: Phenobarbital and neonatal jundice. Clin Pediatr 10:683-684. 1971
8. Caiz C. Jaffe SJ: Pharmacologic modification of bilirubin conjugation in the newborn. Am J Dis Child 104:516-517. 1962
9. Behrman RE, Fisher DE: Phenobarbital for neonatal jaundice. J Pediatr 76:945-948. 1970
10. Bernstein RB, Novy MJ, Piasecki GJ. et al: Bilirubin metabolism in the fetus. J Clin Invest 48:1678-1688. 1969
11. Walker W, Hughes NI, Barton M: Barbiturate and hyperbilirubinemia of prematurity. Lancet 1:548-550, 1969
12. Cunningham MD, Mace JW, Peters ER: Clinical experience with phenobarbitone in icterus neonatorum. Lancet 1:550-551. 1969
13. Trolle D: Phenobarbitone and noenatal icterus. Lancet 1:251-252. 1968
14. Levi AJ, Gatmaigan Z, Arias IM; Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein. and other anions. J Clin Invest 48:2156-2167. 1969
15. Larsen EH. With T: Metabolism of biopigments in infants, with special regard lo icterus neonatorum. Acta Paediatr 31:153-179. 1943
16. Boggs TR Jr. Hardy JB. Frazier TM: Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months: A prelimintary report from the collaborative project. J Pediatr 71:553-560. 1976
17. Sutherland JM. Keller WH: Novobiocin and neonatal hyperbilirubinemia. Am J Dis Child 101:447-453. 1961
18. Arias IM. Gartner LM. Seifter S, et al: Prolonged neonatal unconjugated hyperbilirubinemia associated with breastfeeding and a steroid, pregnane-3 (alpha), 20 (beta)-diol, in maternal milk that inhibits glucuronide formation in vitro. J Clin invest 43:2037-2046, 1964
19. Arias IM. Wolfson S. Lucey JF. et al: Transient familial neonatal hyperbilirubinemia. J Clin Invest 44:1442-1450. 1965
20. Espinosa J. Darneti L. Schnaidt E: The effects of phenobarbital on intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 119:234-238. 1974
21. Wilson JT: Caution with phenobarbital. Clin Pediatr 10:684-687, 1971
22. Gansen SH. Heirwegh KPM. Devríendt A: Foetal bilirubin conjugation. Lancet 1:702-704, 1969